Keywords: USA, FDA, Imported drug assessment, Politics, Fake, Counterfeit drugs

US FDA Commissioner launches PREDICT – a new system for assessing imported drugs risks

Article | 8 February 2010

US Food and Drug Administration Commissioner Margaret Hamburg last week announced the launch of a new risk-assessment tool to ensure the safety of imported drugs and food. The web-based PREDICT (the Predictive Risk-Based Evaluation for Dynamic Import Compliance Targeting ) system will rank the risk hazards of food and drugs as they enter the country and allow inspectors to focus on the most likely threats to public health.

FDA's new PREDICT risk-based screening system for imports will replace the admissibility screening function of OASIS, the FDA's legacy system. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in